Price Transparency Is Not the Same as Affordability and Adherence - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Understanding the Distinction Between Price Transparency, Affordability, and Medication Adherence

  • By

  • Catherine S. Hwang

  • Michael A. Steinman

  • October 5, 2026

Share

  • 1

    Real-time benefit tools (RTBTs) are integrated into clinical workflows to present patient-specific medication costs and suggest lower-cost alternatives.

  • 2

    Studies show mixed results regarding RTBTs' impact on medication dispensing and spending, with limitations including incomplete pharmacy benefits information.

  • 3

    Clinicians report a lack of education on RTBTs, expressing a need for training to improve patient care and reduce administrative burdens.

  • 4

    RTBTs cannot address the root causes of high medication prices, which require broader strategies beyond the capabilities of these tools.

  • 5

    Medication non-adherence is multifactorial, influenced by socioeconomic factors, health literacy, and patient-related issues, not solely by cost.

Original Source(s)

Related Content